Filing Details

Accession Number:
0000950170-24-082686
Form Type:
4
Zero Holdings:
No
Publication Time:
2024-07-10 16:05:04
Reporting Period:
2024-07-08
Accepted Time:
2024-07-10 16:05:04
SEC Url:
Form 4 Filing
Issuer
Cik Name Symbol Sector (SIC) IRS No
886744 Geron Corp GERN Pharmaceutical Preparations (2834) 752287752
Insiders
Cik Name Reported Address Insider Title Director Officer Large Shareholder Other
1270921 J Andrew Grethlein C/O Geron Corporation
919 E. Hillsdale Blvd, Suite 250
Foster City CA 94404
Evp, Chief Operating Officer No No No No
Reported Non-Derivative Transactions
Sec. Name Acquisiton - Disposition Date Amount Price Remaning Holdings Equity Swap Involved Form Type Code Nature of Ownership Explanation
Common Stock Acquisiton 2024-07-08 674,348 $1.72 674,348 No 4 M Direct
Common Stock Disposition 2024-07-08 674,348 $4.56 0 No 4 S Direct
Equity Swap Involved Form Type Code Nature of Ownership Explanation
No 4 M Direct
No 4 S Direct
Reported Derivative Transactions
Sec. Name Sec. Type Acquisiton - Disposition Date Amount Price Amount - 2 Price - 2
Common Stock Stock Option (right to buy) Disposition 2024-07-08 221,544 $0.00 221,544 $1.72
Common Stock Stock Option (right to buy) Disposition 2024-07-08 452,804 $0.00 452,804 $1.72
Remaning Holdings Exercise Date Expiration Date Equity Swap Involved Transaction Form Type Transaction Code Nature of Ownership
0 2028-11-06 No 4 M Direct
0 2028-11-06 No 4 M Direct
Footnotes
  1. The price reported in Column 4 is a weighted average price. These shares were sold in multiple transacations at price ranging from $4.49 to $4.65, inclusive. The reporting person undertakes to provide to the issuer, any security holder of the issuer, or the staff of the Securities and Exchange Commission, upon request, full information regarding the number of shares sold at each seperate price within the range set forth in this footnote.
  2. Option fully vested.